JAGX · Jaguar Health Inc
United States · RS rating 99 · As of 2026-10-14
| Price | 4.18 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 99 / 98 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 38 / 43 / 67 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | +96.7% |
| Sales growth Q/Q | +4.9% |
| Distance from 52-week high | +87.9% |
| Market cap (USD) | $5.1M |